Related Experiment Video
Updated: Jul 2, 2026
03:48
Techniques of Laparoscopic Right Posterior Sectionectomy: Glissonian Approach and a Parenchymal Transection Technique
Published on: October 6, 2023
Ultrasonically activated device for parenchymal division during open hepatectomy
G Belli1, P Limongelli, A Belli
1Department of General and Hepato-Pancreato-Biliary Surgery, S. M. Loreto Nuovo Hospital, Via A. Vespucci, Naples, Italy. chirurgia.loretonuovo@tin.it
Summary
The ultrasonically activated device (USAD) may reduce blood loss in open liver resections. This study found USAD useful in 60 patients, regardless of liver condition, with low morbidity and no in-hospital mortality.
Area of Science:
- Hepatobiliary Surgery
- Surgical Technology
- Minimally Invasive Techniques
Background:
- Technological advancements aim to enhance liver resection safety.
- The ultrasonically activated device (USAD) is a novel technology proposed for open liver resection.
Purpose of the Study:
- To evaluate the usefulness and safety of the ultrasonically activated device (USAD) in open liver resection.
- To assess the impact of USAD on perioperative outcomes in liver surgery.
Main Methods:
- A prospective analysis of 60 patients undergoing open liver resection using USAD.
- Data collected included operation time, blood loss, transfusion requirements, morbidity, and mortality.
Main Results:
- Mean operation time was 172 minutes with a mean blood loss of 410 mL.
- Morbidity rate was 20% (12/60 patients), with no in-hospital mortality recorded.
- No significant differences in outcomes were observed between patients with and without cirrhosis.
Conclusions:
- USAD may help minimize blood loss during liver resection.
- Further controlled studies with larger patient cohorts are needed.
- USAD appears beneficial regardless of liver condition, including cirrhosis.
